(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ATARA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ATARA

ST13

US500000098486779

Class

5

Filing

98486779

Registration

7651932

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

11/28/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

04/05/2024

Registration date

01/14/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/14/2025

Last transaction

11/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

10/26/2017

First use in commerce

10/26/2017

Drawing code

4

Owner type

03

Owner location

Thousand Oaks, CA

Examiner

KING,LINDA M

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Atara Biotherapeutics, Inc.

Representatives

Lynne Boisineau Boisineau Law, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseasescancerkidney diseasediabetescachexiaage related sarcopeniaprotein-energy wastingmultiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders; none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis

Publications

History of USPTO decisions and trademark events.

14 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/10/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/26/2024

PUBO

PUBLISHED FOR OPPOSITION

11/26/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/20/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/21/2024

DOCK

ASSIGNED TO EXAMINER

10/21/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2024

NWAP

NEW APPLICATION ENTERED

04/05/2024

Continuous trademark protection

Get notified about every new filing that threatens ATARA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.